This guide was put together using insights from individuals working directly on Pharma/CMO relationships. In each case we asked individuals how they would tackle a particular CMO crisis and have collated their insights into this handy guide. Example of a CMO crisis included in this guide is; How would you collect and react fast if a batch was rejected in order to keep the supply chain safe?
With insights from over 50 individuals within the Pharma industry, and accompanied by commentary from Ulrich Ruemenapp, Head of Launch Preparation, Bayer this report will take an in-depth look at the most important components when selecting a CMO, the greatest risks when choosing to outsource and best practises for managing CMO networks.
This report will explore:
- Which Key elements you need to prioritise to allow you to reduce your external partner footprint
- The greatest risks when choosing to outsource
- The characteristics sponsors most value in a CMO
Emerging markets can be highly competitive in terms of price when looking to outsource manufacturing, and with many technology advances they are catching up in with more developed regions in other areas.
We spoke to Luiz Barberini, Operations Manager - External Manufacturing Latin America, Bayer to discuss with him the latest trends and opportunities, and the specific challenges of outsourcing in a less developed regions.
Download your free copy of the article by filling in the form on the right >>
This piece will cover:
- The latest trends and opportunities for sponsors in the LatAm region
- The opportunities provided by emerging markets
- Issues that arise with geographical separation when managing a successful partnership
Fill in the form on the right to receive your copy of the article >>
We have put together a handbook of exclusive information on some of the most pertinent issues facing the sector. This handbooks draws on the discussions of leading experts and real-life experiences shared at the 2018 Pharma Contract Manufacturing conference, and will serve as a guide to navigating the challenges of Pharma/CMO relationships and best practises for building long-lasting strategic partnerships for the future.
We spoke exclusively with Luiz Barberini, Sr. Operations Manager - External Manufacturing Latin America, Bayer about how he manages relationships with contract manufacturers.
From this discussion we have put together this handy pocket guide which covers topics including conflict management, mitigating risks and building resourceful and lasting relationships with contractors.
Nowadays, nearly 80% of drugs currently FDA approved on behalf of small bio/pharma companies are contract manufactured, and 50% of products supported by mid-size companies use a CMO. In the lead up to the Pharma Contract Manufacturing Conference, Pharma IQ have looked at the evolution of the roles of CMOs and CDMOs in the industry, and what the future will bring for these organisations.
When building a resourceful and reliable relationship with a CMO it is critical that both companies understand each other’s culture, mission and values. Pharma IQ caught up with Christophe Stevens, Associate Director External Manufacturing, UCB and Christophe Defrance, External Manufacturing Director, UCB to discuss the optimisation and consolidation of their extensive CMO network.